• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ETHICON INC. SURGICEL NU-KNIT 6INX9IN(15.2CMX22.9CM); AGENT, ABSORBABLE HEMOSTATIC, NON-COLLAGEN BASED

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ETHICON INC. SURGICEL NU-KNIT 6INX9IN(15.2CMX22.9CM); AGENT, ABSORBABLE HEMOSTATIC, NON-COLLAGEN BASED Back to Search Results
Catalog Number 1946
Medical Device Problem Code Adverse Event Without Identified Device or Use Problem (2993)
Health Effect - Clinical Code Unspecified Infection (1930)
Type of Reportable Event Serious Injury
Additional Manufacturer Narrative
Product complaint # (b)(4).To date the device has not been returned.If the device or further details are received at a later date a supplemental medwatch will be sent.Additional information was requested and the following was obtained: the patient demographic info: age, gender, weight, bmi at the time of index procedure? no further information is available.Date of index surgical procedure? no further information is available.The diagnosis and indication for the index surgical procedure? pancreaticoduodenectomy.Relevant patient history? no further information is available.Any concurrent use of other products? no further information is available.Where was the surgicel used (on what tissue)? in the abdominal cavity.How much surgicel was used during the procedure? no further information is available.Was the surgicel product left in place? the surgeon said the surgicel nu-knit was left in the abdominal cavity as it was for hemostasis, but detailed information is not available.What were current symptoms following the index surgical procedure? onset date? no further information is available.Were cultures performed? if yes, results? no further information is available.Has any surgical or medical intervention been performed? no further information is available.What is physician¿s opinion as to the etiology of or contributing factors to this event? no further information is available.Was there an alleged deficiency of the surgicel that contributed to the patient¿s post-operative infection? no further information is available.No further information will be provided.
 
Event or Problem Description
It was reported that a patient underwent a pancreaticoduodenectomy procedure on an unknown date and an absorbable hemostat was used.The patient experienced and infection.It is unknown how the absorbable hemostat was used.It was left in the abdominal cavity as it was for hemostasis during wound closure because the device would be absorbed.The patient was discharged from the hospital.The event was not serious.Further details were not provided from the hospital.Additional information was requested.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
SURGICEL NU-KNIT 6INX9IN(15.2CMX22.9CM)
Common Device Name
AGENT, ABSORBABLE HEMOSTATIC, NON-COLLAGEN BASED
Manufacturer (Section D)
ETHICON INC.
p.o. box 151, route 22 west
somerville NJ 08876 0151
MDR Report Key8911253
Report Number2210968-2019-85826
Device Sequence Number11247272
Product Code LMG
UDI-Device Identifier10705031002999
UDI-Public10705031002999
Combination Product (Y/N)N
Initial Reporter CountryJA
PMA/510(K) Number
N12159
Number of Events Summarized1
Summary Report (Y/N)N
Reporter Type Manufacturer
Report Source company representative,foreig
Initial Reporter Occupation Other
Type of Report Initial
Report Date (Section B) 07/24/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Operator of Device Health Professional
Device Expiration Date09/30/2023
Device Catalogue Number1946
Device Lot NumberMPE3431
Was Device Available for Evaluation? No
Type of Report(Section G)Initial
Initial Date Received by Manufacturer 07/24/2019
Initial Report FDA Received Date08/20/2019
Patient Sequence Number1
Outcome Attributed to Adverse Event Required Intervention;
-
-